{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=2&page=85", "query": { "intervention": "2", "page": 85 }, "page_size": 10 }, "pagination": { "page": 85, "page_size": 10, "total_count": 79351, "total_pages": 7936, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=2&page=86&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=2&page=84&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-10T11:38:21.354Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00570739", "title": "Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes Mellitus", "Hypercholesterolemia", "Pre-diabetes" ], "interventions": [ { "name": "Metformin HCl and Colesevelam Placebo", "type": "DRUG" }, { "name": "Metformin HCl tablets and Colesevelam tablets", "type": "DRUG" }, { "name": "Colesevelam placebo", "type": "DRUG" }, { "name": "Colesevelam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 502, "start_date": "2007-11", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2010-07-27", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Los Gatos, California • Tarzana, California + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Gatos", "state": "California" }, { "city": "Tarzana", "state": "California" }, { "city": "Ocala", "state": "Florida" }, { "city": "Pocatello", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT00570739" }, { "nct_id": "NCT02706977", "title": "The Effect of Dopamine on Diabetic Retinopathy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diabetes" ], "interventions": [ { "name": "Low Dose Sinemet CR", "type": "DRUG" }, { "name": "High Dose Sinemet CR", "type": "DRUG" }, { "name": "RETeval Electroretinogram (ERG) Testing", "type": "DEVICE" }, { "name": "Contrast Sensitivity Testing", "type": "OTHER" }, { "name": "Visual Acuity Testing", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DEVICE", "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 60, "start_date": "2016-01", "completion_date": "2019-08-15", "has_results": false, "last_update_posted_date": "2019-10-09", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02706977" }, { "nct_id": "NCT04550377", "title": "Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Post Traumatic Stress Disorder", "Traumatic Brain Injury" ], "interventions": [ { "name": "Cannabidiol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 120, "start_date": "2021-05-26", "completion_date": "2026-06", "has_results": false, "last_update_posted_date": "2026-02-17", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04550377" }, { "nct_id": "NCT00756275", "title": "Varenicline and Motivational Advice for Smokers With Substance Use Disorders", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Cessation", "Nicotine Dependence" ], "interventions": [ { "name": "Nicotine Replacement Treatment (NRT)", "type": "DRUG" }, { "name": "varenicline", "type": "DRUG" }, { "name": "Behavioral counseling for smoking cessation", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "Brown University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 158, "start_date": "2009-01", "completion_date": "2014-09", "has_results": true, "last_update_posted_date": "2018-08-27", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT00756275" }, { "nct_id": "NCT03352557", "title": "Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "BIIB092", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "50 Years to 80 Years" }, "enrollment_count": 654, "start_date": "2018-05-03", "completion_date": "2021-08-30", "has_results": true, "last_update_posted_date": "2022-11-08", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 52, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 41 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03352557" }, { "nct_id": "NCT05199857", "title": "WE BEAT - HEART Club Fontan Wellness Project: A Virtual Resilience Promotion and Frailty Prevention Program", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Fontan Physiology", "Frailty", "Single Ventricle Heart Disease" ], "interventions": [ { "name": "WE BEAT Group Wellness Education program - phase 1", "type": "BEHAVIORAL" }, { "name": "HEART Club Home Exercise program - phase 2", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "13 Years to 18 Years" }, "enrollment_count": 30, "start_date": "2022-03-30", "completion_date": "2026-07-01", "has_results": false, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05199857" }, { "nct_id": "NCT00694512", "title": "Ghrelin Regulation and Structure: Effect of Diet Composition on Ghrelin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Low fat diet", "type": "DIETARY_SUPPLEMENT" }, { "name": "High fat diet", "type": "DIETARY_SUPPLEMENT" }, { "name": "MCT diet", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 51, "start_date": "2008-02", "completion_date": "2011-03", "has_results": false, "last_update_posted_date": "2012-05-15", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00694512" }, { "nct_id": "NCT04660812", "title": "An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metastatic Colorectal Cancer" ], "interventions": [ { "name": "AB680", "type": "DRUG" }, { "name": "Etrumadenant", "type": "DRUG" }, { "name": "Zimberelimab", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" }, { "name": "m-FOLFOX-6 regimen", "type": "DRUG" }, { "name": "Regorafenib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Arcus Biosciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 227, "start_date": "2021-05-10", "completion_date": "2025-09-05", "has_results": false, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 17, "location_summary": "Tucson, Arizona • Duarte, California • Santa Monica, California + 12 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04660812" }, { "nct_id": "NCT00087581", "title": "Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Kidney Transplantation" ], "interventions": [ { "name": "Mycophenolate mofetil", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "13 Years to 75 Years" }, "enrollment_count": 720, "start_date": "2004-06", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2016-11-07", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 57, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Bakersfield, California + 48 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00087581" }, { "nct_id": "NCT02279719", "title": "A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hepatocellular Carcinoma" ], "interventions": [ { "name": "BBI608", "type": "DRUG" }, { "name": "BBI503", "type": "DRUG" }, { "name": "Sorafenib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 97, "start_date": "2014-12", "completion_date": "2019-10", "has_results": true, "last_update_posted_date": "2023-11-15", "last_synced_at": "2026-11-10T11:38:21.354Z", "location_count": 29, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Coronado, California + 25 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Coronado", "state": "California" }, { "city": "Encinitas", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02279719" } ] }